But What are Patients Thinking About Ai?

Artificial Intelligence (AI) is rapidly transforming healthcare, promising to enhance diagnosis accuracy, improve patient engagement, and streamline care delivery.

Yet, as these innovations take center stage, it is crucial for pharma brand marketers, innovation teams, and those supporting patient access and care to understand the perspectives of the most important stakeholders—patients themselves.

What do patients really think about AI in their healthcare journey?

This article examines patient attitudes, perceived benefits and concerns, and the factors influencing trust in AI-driven solutions. By unpacking these viewpoints, we reveal how pharma and patient support teams can craft strategies that align with real patient needs and expectations, ultimately maximizing both technological and therapeutic impact.

Patient Sentiment: Hope, Hesitation, and the Pursuit of Value

Recent surveys and qualitative research indicate that patient sentiment toward AI in healthcare is deeply nuanced. According to a 2023 Pew Research Center report, about 60% of U.S. adults are generally optimistic that AI can improve healthcare outcomes, particularly in diagnosis and monitoring. However, optimism is tempered by significant reservations.

A recurring theme in patient feedback is a hope for increased speed and accuracy in diagnosis. Patients who have endured lengthy diagnostic journeys, particularly those with rare or complex conditions, see AI as a means to reduce uncertainty and error—a theme echoed in studies published by the Journal of Medical Internet Research (JMIR) in 2023. Ai-driven tools, like predictive algorithms for cancer detection and personalized medicine apps, are seen as value enhancers, delivering relevant, timely interventions that empower patients with information and options.

Yet, hesitation remains. Patients voice apprehension around data privacy, algorithmic transparency, and loss of the human touch. Many are concerned about how their health data is used and whether AI will override clinician judgment or lead to depersonalized care. Notably, a 2023 Deloitte Insight survey found that over 50% of patients want clear explanations about how AI tools influence treatment.

For pharma innovators and patient support teams, the implication is clear: embracing AI’s promise means prioritizing communication, transparency, and the preservation of empathetic human relationships. As digital adoption accelerates, these patient perspectives must guide development and marketing strategies.

Barriers to Trust and Adoption: Privacy, Transparency, and Human Connection

Trust is the linchpin of AI adoption in healthcare, yet three major barriers consistently emerge in patient discourse: privacy, transparency, and the fear of diminished human oversight.

First, privacy remains a top concern. The proliferation of AI-powered platforms necessitates the collection and processing of sensitive health data. Incidents of data breaches and unclear disclosures have eroded trust, making patients acutely aware of who accesses their information.

According to a HIMSS 2024 survey, more than 65% of respondents said the most crucial aspect of AI healthcare solutions is robust data protection and user consent protocols. Ensuring robust cybersecurity, transparent data handling policies, and patient-controlled permissions is not optional; it is foundational.

Second, algorithmic transparency is pivotal. Patients increasingly demand to know how AI tools arrive at recommendations—whether for drug selection, risk prediction, or disease monitoring. Lack of clarity propels concerns about potential biases and the fairness of automated decisions. For pharma brands integrating AI into support teams or patient-facing solutions, embedding explainability and involving clinicians in AI-driven decision-making creates a necessary bridge to trust.

Finally, there is a palpable fear of losing the human element in care. While AI can process vast quantities of data rapidly, patients fear that over-reliance may result in impersonal interactions or reduce access to empathetic, skilled clinicians.

Clinical AI tools need to augment—not replace—human intelligence. Pharmaceutical innovation teams must integrate AI solutions that facilitate, rather than supplant, meaningful human engagement, and offer training to support teams in combining both digital and interpersonal skills.

How AI Can Deliver Value for Patients: Personalization, Convenience, and Better Outcomes

Despite their reservations, patients increasingly recognize the tangible benefits AI can deliver—if appropriately deployed. The value of AI is often seen in how well it addresses longstanding patient pain points in the healthcare system.

Personalization is a key differentiator. Advanced AI platforms, such as those used in patient support programs, now analyze behavioral and biometric data to tailor interventions, reminders, and educational content. This “precision support” translates to better adherence, timely interventions, and improved outcomes—demonstrated in several clinical studies, including a 2024 trial published in Nature Medicine, which showed that AI-augmented digital health tools improved medication adherence rates by over 20% compared to traditional methods. Convenience is another considerable benefit.

AI chatbots, virtual health assistants, and scheduling tools streamline administrative hurdles, reducing wait times and improving patient navigation across complex care pathways. By minimizing friction, AI helps patients retain agency in their care journey—a powerful contributor to satisfaction and engagement. Perhaps most importantly, better health outcomes are increasingly observable.

Machine learning models now identify at-risk patients, prompt early interventions, and guide medication management with unprecedented accuracy. These real-world improvements reinforce the perceived value of AI; however, the success hinges on maintaining trust and upholding ethics, as discussed in previous sections.

Shaping the Future: Recommendations for Pharma and Support Teams

For pharma brand marketers, innovation teams, and patient support stakeholders, understanding patient perspectives offers a strategic advantage—enabling the design and rollout of AI solutions that resonate with real-world needs. Key recommendations include:

1) Embed transparency into every AI interaction—ensure that patients understand how, why, and when AI tools are used in their care.
2) Make privacy foundational—implement world-class security and data sovereignty to reassure patients and regulators alike.
3) Prioritize human touch—equip support teams with training to complement digital solutions, reinforcing empathy and trust.
4) Co-create with patients—engage patient advisory boards and diverse user groups early in AI solution design, ensuring outputs reflect a broad array of lived experiences.
5) Measure and report outcomes—regularly track and share the quantitative and qualitative impact of AI-enabled tools on patient journeys.

By centering strategies on patient voices, pharma and patient support teams not only differentiate their offerings but also foster long-term loyalty and health impact.

Conclusion

The integration of AI in healthcare holds enormous promise, but its ultimate value is determined by how well it meets patient expectations and addresses their concerns.

Patients are cautiously optimistic, eager for the efficiency, personalization, and improved outcomes AI can bring, but unwilling to sacrifice privacy or the human touch. For pharma marketers and support teams, the path to successful AI adoption lies in balancing technical innovation with uncompromising commitment to trust, transparency, and patient-centricity.

Engaging deeply with patients as co-creators of digital health solutions will be key not only to acceptance but to transformational progress in healthcare delivery.

More from Medisafe:

• Get a call from Medisafe’s AI Voice Agent: https://www.medisafevia.com
• More on Medisafe’s Just-in-Time-Intervention AI Solutions: https://www.medisafe.com/jiti
• See all Medisafe Solutions: https://www.medisafe.com/solutions